Lwona Dobler

3PUBLICATIONS
16CO-AUTHORS
Haematological tumoursPharmacogenomicsBiologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

Sort by Publication Date:
|Apr 12, 2022
Correction to: A Phase 1 Study of Sapanisertib (TAK-228) in East Asian Patients with Advanced Nonhematological Malignancies.

Toshio Shimizu, Yasutoshi Kuboki, Chia-Chi Lin

|Nov 29, 2021
A Phase 1 Study of Sapanisertib (TAK-228) in East Asian Patients with Advanced Nonhematological Malignancies.

Toshio Shimizu, Yasutoshi Kuboki, Chia-Chi Lin

|Jan 20, 2018
Pevonedistat, a first-in-class NEDD8-activating enzyme inhibitor, combined with azacitidine in patients with AML.

Ronan T Swords, Steven Coutre, Michael B Maris

Pageof 1

Frequent Collaborators

3 joint publications

Douglas V Faller

2 joint publications

Neeraj Gupta

2 joint publications

Tomoko Yanai

2 joint publications

Saran Vardhanabhuti

2 joint publications

Kyu-Pyo Kim

2 joint publications

Kan Yonemori

2 joint publications

Chia-Chi Lin

2 joint publications

Toshio Shimizu

2 joint publications

Yasutoshi Kuboki

1 joint publications

Joshua F Zeidner

Frequent Collaborators

3 joint publications

Douglas V Faller

2 joint publications

Neeraj Gupta

2 joint publications

Tomoko Yanai

2 joint publications

Saran Vardhanabhuti

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us

Top Related Videos

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3
08:36

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3

Published on : Apr 07, 2023

1.2K
Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals
09:31

Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals

Published on : Apr 15, 2017

19.1K
See more related videos

Top Related Videos

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3
08:36

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3

Published on : Apr 07, 2023

1.2K
Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals
09:31

Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals

Published on : Apr 15, 2017

19.1K
See more related videos